Michael Gelband’s National Healthcare NHC Stock Holding History

Michael Gelband’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,365	Closed	-$697K	–	1908
2026 Q1	$697K	Buy	+4,365	New	+$670K	0.01%	1098
2025 Q3	–	Sell	-12,375	Closed	-$1.32M	–	1860
2025 Q2	$1.32M	Sell	12,375 -6,450	-34%	-$645K	0.01%	875
2025 Q1	$1.75M	Buy	18,825 +11,547	+159%	+$1.12M	0.02%	740
2024 Q4	$783K	Buy	7,278 +3,925	+117%	+$478K	0.01%	1019
2024 Q3	$422K	Buy	+3,353	New	+$422K	﹤0.01%	1254
2023 Q2	–	Sell	-3,597	Closed	-$209K	–	2125
2023 Q1	$209K	Buy	+3,597	New	+$207K	﹤0.01%	1567
2021 Q4	–	Sell	-13,560	Closed	-$949K	–	2460
2021 Q3	$949K	Sell	13,560 -4,692	-26%	-$341K	0.01%	1050
2021 Q2	$1.28M	Buy	+18,252	New	+$1.33M	0.01%	879
2020 Q4	–	Sell	-16,334	Closed	-$1.02M	–	2244
2020 Q3	$1.02M	Buy	+16,334	New	+$1.02M	0.02%	673
2019 Q3	–	Sell	-2,722	Closed	-$221K	–	1535
2019 Q2	$221K	Buy	+2,722	New	+$210K	0.01%	870

Other funds holding NHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MSIIA

Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.07B AUM 29.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Michael Gelband's NHC Position: Q2 2026 in Review

Michael Gelband sold out of National Healthcare (NHC) in Q2 2026, closing a stake of 4,365 shares — an estimated $697K sold.

Michael Gelband first reported a position in NHC in Q2 2019 and held it in 10 quarters. The position peaked at $1.75M in Q1 2025. 246 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

Michael Gelband reported no remaining National Healthcare position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 4,365 National Healthcare shares in Q2 2026, an estimated $697K.
Michael Gelband first reported a position in National Healthcare in Q2 2019 and held it in 10 quarters.
Michael Gelband's National Healthcare position peaked at $1.75M in Q1 2025.
246 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.